BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells

Area of Science:

• Immunology
• Cell Biology
• Transplantation Immunology

Background:

• Ig-like transcript 3 (ILT3) is an inhibitory receptor on tolerogenic dendritic cells.
• ILT3 plays a role in immune regulation and tolerance induction.

Purpose of the Study:

• To investigate the role of ILT3-Fc in T cell differentiation and function.
• To explore the potential of ILT3-Fc as an immunosuppressive agent for islet transplantation.

Main Methods:

• Allostimulation of human CD8(+) T cells with recombinant ILT3-Fc protein.
• Analysis of T suppressor (Ts) cell differentiation and function.
• Assessment of BCL6 expression and its necessity for Ts cell activity.
• Graft tolerance studies in NOD/SCID mice with humanized islets and PBMCs.

Main Results:

• ILT3-Fc induces CD8(+) T cells to differentiate into antigen-specific T suppressor (Ts) cells.
• BCL6 expression is critical for the function of ILT3-Fc-induced Ts cells.
• ILT3-Fc treatment promotes pancreatic islet graft tolerance in vivo by generating BCL6(high) CD8(+) Ts cells.

Conclusions:

• ILT3-Fc is a potent immunosuppressive agent that acts via BCL6 to induce Ts cells.
• ILT3-Fc can reverse or prevent autoimmune/allogeneic attacks on pancreatic islets.
• This mechanism offers a novel therapeutic strategy for transplantation and autoimmune diseases.